HOME >> BIOLOGY >> NEWS
European Science Foundation's Forward Look reaches out beyond the endless frontiers

Forward Look exercise on Nanomedicine. The Forward Look exercise has been considered as an important source of inspiration for the European Commissions Strategic Research Agenda of the European Technology Platform on Nanomedicine and has left impactful marks on the ECs Seventh Framework Programme calls.

Three of the more recent Forward Looks topics are focused on developments and challenges in the natural sciences. These Forward Looks have all included some typical foresight methods, such as scenario building, road mapping, interactive workshops or key word analysis. In the Forward Look Nanomedicine, a SWOT analysis (evaluating the Strengths, Weaknesses, Opportunities and Threats for Europe in an international context) was used to structure the current state of affairs and future developments.

The Forward Looks final reports, as the one on Nanosciences and the Long-term Evolution of Information Technology (NSIT), typically develop science policy recommendations and strategies at the European level. These reports are aware that the Forward Look is part of a broader policy-making process needing coherent and comprehensive recommendations, and their conclusions take into account the opportunities and weaknesses of the current structures and dynamics of the European Research Area. Moreover, the priorities suggested by these reports are more explicit in the sense that they are not just seen as new emerging themes but as frameworks to coordinate the dynamics of these specific fields at an international level.

In the Forward Look Systems Biology a plea is made to create a European road map to develop the Grand Challenge on Systems Biology for Europe.

The current invitation for significant Forward Look topics, pronounced by the ESF in July 2007, is expected to initiate once more foresight exercises at the highest scientific level with European relevance.

Impacts of former and present Forward Looks

'"/>

Contact: Christoph Ettl
cettl@esf.org
33-388-767-154
European Science Foundation
8-Aug-2007


Page: 1 2 3 4 5 6

Related biology news :

1. The UAB heads a European research project on proteases and pathological processes
2. Journalists can register now for ECCO 14 -- the European Cancer Conference
3. Climate changes brews trouble for marine life in European Seas, Marine Board-ESF report says
4. Early Europeans unable to stomach milk
5. European launch of International Polar Year 2007-2008
6. IDIBAPS participates in European Network on antibiotic resistances and hospital infections
7. European approval of HIV drug darunavir will provide a potent new option with Fuzeon
8. European launch of International Polar Year 2007-2008
9. European Federation of Biotechnology and Elsevier announce launch of biotechnology journal
10. Putting a face on the earliest modern Europeans
11. European Union outpaces United States on chemical safety

Post Your Comments:
(Date:10/15/2014)... from strains of influenza virus increases with the latest ... complacent that the most substantial threats have been identified, ... arise when a new virus strain – against which ... in the human population. There have been five such ... which – the 1918 Spanish Flu – cost 50 ...
(Date:10/15/2014)... NXT-ID, Inc. (NASDAQ: NXTD and NXTDW) ... growing mobile commerce market releases photos and video of the recent ... October 13 th . Gino Pereira , ... angel investor Mr. Chad A. Verdi rang the bell.  ... his investors and employees "for their work and dedication in bringing ...
(Date:10/14/2014)... of years since T. rex took its ... scientists is breathing life back into dinosaurs using high-powered ... research has important implications for how dinosaurs used their ... sense of smell and cool their brains. , ... student Jason Bourke, lead author of the new study ...
Breaking Biology News(10 mins):Scientists 'must not become complacent' when assessing pandemic threat from flu viruses 2Photo Release: NXT-ID Inc. Rings Opening Bell of the NASDAQ Stock Market October 13th 2Photo Release: NXT-ID Inc. Rings Opening Bell of the NASDAQ Stock Market October 13th 3Dinosaur breathing study shows that noses enhanced smelling and cooled brain 2Dinosaur breathing study shows that noses enhanced smelling and cooled brain 3
(Date:10/25/2014)... (PRWEB) October 24, 2014 The ... the nation’s leading nonprofit authority on the use ... information exchange, announces its appointment of four new ... The workgroup leaders include:, ,     Peter ...     Erik Pupo, Specialist Leader, Deloitte Consulting LLP ...
(Date:10/25/2014)... (PRWEB) October 24, 2014 SonaCare ... focused ultrasound (HIFU) technology, announced that its Board ... as Chief Executive Officer, President and member of ... Dr. Carol will take-on expanded responsibilities within the ... as well as overseeing commercialization, manufacturing and finance. ...
(Date:10/25/2014)... , October 24, 2014 ... clinical-stage pharmaceutical company focused on the development of oral ... Nadav Kidron will present at FireRock Capital,s ... Capital,s Annual Micro-Cap Conference ,Date: Tuesday, October 28, 2014 ... New York City , ...
(Date:10/25/2014)... -- Investor-Edge has initiated coverage on the ... Vertex Pharmaceuticals Inc. (NASDAQ: VRTX ), Alexion ... Inc. (NASDAQ: PPHM ), and StemCells Inc. ... be accessed at: http://investor-edge.com/register . The ... a positive note as the Dow Jones Industrial Average ...
Breaking Biology Technology:WEDI Appoints Four New Security and Privacy Workgroup Co-chairs 2SonaCare Medical Board of Directors Appoints Dr. Mark Carol as CEO and President 2SonaCare Medical Board of Directors Appoints Dr. Mark Carol as CEO and President 3Oramed to Present at the FireRock Annual Micro-Cap Conference 2Oramed to Present at the FireRock Annual Micro-Cap Conference 3Biotech Stocks Technical Data - CytRx, Vertex Pharma, Alexion Pharma, Peregrine Pharma, and StemCells 2Biotech Stocks Technical Data - CytRx, Vertex Pharma, Alexion Pharma, Peregrine Pharma, and StemCells 3Biotech Stocks Technical Data - CytRx, Vertex Pharma, Alexion Pharma, Peregrine Pharma, and StemCells 4Biotech Stocks Technical Data - CytRx, Vertex Pharma, Alexion Pharma, Peregrine Pharma, and StemCells 5
Cached News: